mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
GDC-0449 |
FIMM |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.0033 |
0.9 |